vs
Chatham Lodging Trust（CLDT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Chatham Lodging Trust的1.0倍（$69.8M vs $67.7M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 6.8%，领先377.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -9.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -0.5%）
查塔姆住宿信托是一家专注于投资、持有及运营高端长住型和精选服务类酒店物业的房地产投资信托，主要布局美国高需求的城市及城郊市场，服务商务与休闲旅客群体，追求长期稳定的现金流收益。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CLDT vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$67.7M
营收增速更快
RIGL
高出31.0%
-9.8%
净利率更高
RIGL
高出377.2%
6.8%
两年增速更快
RIGL
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.7M | $69.8M |
| 净利润 | $4.6M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 15.9% | 33.2% |
| 净利率 | 6.8% | 384.0% |
| 营收同比 | -9.8% | 21.2% |
| 净利润同比 | 369.9% | 1769.2% |
| 每股收益（稀释后） | $0.05 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLDTRIGL
| Q4 25 | $67.7M | $69.8M | ||
| Q3 25 | $78.4M | $69.5M | ||
| Q2 25 | $80.3M | $101.7M | ||
| Q1 25 | $68.6M | $53.3M | ||
| Q4 24 | $75.1M | $57.6M | ||
| Q3 24 | $87.2M | $55.3M | ||
| Q2 24 | $86.5M | $36.8M | ||
| Q1 24 | $68.4M | $29.5M |
净利润CLDTRIGL
| Q4 25 | $4.6M | $268.1M | ||
| Q3 25 | $3.5M | $27.9M | ||
| Q2 25 | $5.4M | $59.6M | ||
| Q1 25 | $1.5M | $11.4M | ||
| Q4 24 | $-1.7M | $14.3M | ||
| Q3 24 | $4.3M | $12.4M | ||
| Q2 24 | $6.8M | $-1.0M | ||
| Q1 24 | $-5.2M | $-8.2M |
毛利率CLDTRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | 40.7% | 89.9% | ||
| Q3 24 | 44.7% | 85.5% | ||
| Q2 24 | 46.1% | 92.4% | ||
| Q1 24 | 38.9% | 93.1% |
营业利润率CLDTRIGL
| Q4 25 | 15.9% | 33.2% | ||
| Q3 25 | 12.7% | 40.9% | ||
| Q2 25 | 14.8% | 60.1% | ||
| Q1 25 | 12.1% | 23.9% | ||
| Q4 24 | 7.5% | 28.9% | ||
| Q3 24 | 14.3% | 25.4% | ||
| Q2 24 | 16.3% | 1.2% | ||
| Q1 24 | 1.4% | -23.6% |
净利率CLDTRIGL
| Q4 25 | 6.8% | 384.0% | ||
| Q3 25 | 4.5% | 40.2% | ||
| Q2 25 | 6.7% | 58.6% | ||
| Q1 25 | 2.2% | 21.5% | ||
| Q4 24 | -2.3% | 24.9% | ||
| Q3 24 | 4.9% | 22.5% | ||
| Q2 24 | 7.9% | -2.8% | ||
| Q1 24 | -7.6% | -27.9% |
每股收益（稀释后）CLDTRIGL
| Q4 25 | $0.05 | $14.11 | ||
| Q3 25 | $0.03 | $1.46 | ||
| Q2 25 | $0.07 | $3.28 | ||
| Q1 25 | $-0.01 | $0.63 | ||
| Q4 24 | $-0.08 | $0.82 | ||
| Q3 24 | $0.05 | $0.70 | ||
| Q2 24 | $0.10 | $-0.06 | ||
| Q1 24 | $-0.15 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.4M | $155.0M |
| 总债务越低越好 | $338.9M | $52.5M |
| 股东权益账面价值 | $740.8M | $391.5M |
| 总资产 | $1.2B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.46× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CLDTRIGL
| Q4 25 | $24.4M | $155.0M | ||
| Q3 25 | $13.2M | $137.1M | ||
| Q2 25 | $17.2M | $108.4M | ||
| Q1 25 | $18.6M | $77.1M | ||
| Q4 24 | $20.2M | $77.3M | ||
| Q3 24 | $19.3M | $61.1M | ||
| Q2 24 | $10.6M | $49.1M | ||
| Q1 24 | $72.3M | $49.5M |
总债务CLDTRIGL
| Q4 25 | $338.9M | $52.5M | ||
| Q3 25 | $338.8M | $60.0M | ||
| Q2 25 | $351.2M | $60.0M | ||
| Q1 25 | $381.1M | $60.0M | ||
| Q4 24 | $406.9M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CLDTRIGL
| Q4 25 | $740.8M | $391.5M | ||
| Q3 25 | $749.4M | $117.6M | ||
| Q2 25 | $754.1M | $81.9M | ||
| Q1 25 | $754.7M | $18.6M | ||
| Q4 24 | $758.2M | $3.3M | ||
| Q3 24 | $765.3M | $-14.6M | ||
| Q2 24 | $766.5M | $-29.9M | ||
| Q1 24 | $765.0M | $-31.7M |
总资产CLDTRIGL
| Q4 25 | $1.2B | $513.6M | ||
| Q3 25 | $1.2B | $242.5M | ||
| Q2 25 | $1.2B | $206.7M | ||
| Q1 25 | $1.2B | $176.0M | ||
| Q4 24 | $1.3B | $164.0M | ||
| Q3 24 | $1.3B | $139.4M | ||
| Q2 24 | $1.3B | $128.4M | ||
| Q1 24 | $1.3B | $126.5M |
负债/权益比CLDTRIGL
| Q4 25 | 0.46× | 0.13× | ||
| Q3 25 | 0.45× | 0.51× | ||
| Q2 25 | 0.47× | 0.73× | ||
| Q1 25 | 0.50× | 3.23× | ||
| Q4 24 | 0.54× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $64.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 13.90× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLDTRIGL
| Q4 25 | $64.1M | $22.0M | ||
| Q3 25 | $25.6M | $24.0M | ||
| Q2 25 | $22.1M | $30.5M | ||
| Q1 25 | $4.2M | $-893.0K | ||
| Q4 24 | $73.8M | $14.5M | ||
| Q3 24 | $28.8M | $21.7M | ||
| Q2 24 | $25.2M | $302.0K | ||
| Q1 24 | $6.9M | $-5.0M |
现金转化率CLDTRIGL
| Q4 25 | 13.90× | 0.08× | ||
| Q3 25 | 7.24× | 0.86× | ||
| Q2 25 | 4.10× | 0.51× | ||
| Q1 25 | 2.73× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 6.78× | 1.75× | ||
| Q2 24 | 3.68× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLDT
| Occupancy | $61.5M | 91% |
| Hotel Other | $4.2M | 6% |
| Food And Beverage | $1.8M | 3% |
| Hotel | $1.1M | 2% |
RIGL
暂无分部数据
